Summary. The response of an experimental sarcoma to single doses and two fractions of x-rays and fast neutrons has been investigated to test the hypothesis that slowly shrinking sarcomata will reoxygenate poorly and therefore will benefit more from fractionated neutron treatment than from fractionated x-ray treatment, in contrast with rapidly shrinking carcinomata. Neutrons were approximately three times more effective than x-rays, both for single doses and for two fractions given in 48 hours, when regrowth was used as a measure of response. This observation is closely similar to results previously obtained on a rat fibrosarcoma and contrasts with previous results from a mouse mammary carcinoma, and is in agreement with the hypothesis.
Summary. The response of an experimental sarcoma to single doses and two fractions of x-rays and fast neutrons has been investigated to test the hypothesis that slowly shrinking sarcomata will reoxygenate poorly and therefore will benefit more from fractionated neutron treatment than from fractionated x-ray treatment, in contrast with rapidly shrinking carcinomata. Neutrons were approximately three times more effective than x-rays, both for single doses and for two fractions given in 48 hours, when regrowth was used as a measure of response. This observation is closely similar to results previously obtained on a rat fibrosarcoma and contrasts with previous results from a mouse mammary carcinoma, and is in agreement with the hypothesis.
MOST animal solid tumours have been found to contain hypoxic cells (e.g. Thomlinson, 1960; Hewitt, Chan and Blake, 1967; Van Putten and Kallman, 1968) and single doses of neutrons have been found to be more effective in damaging such tumours, relative to the effect on normal tissues, than single doses of x or y rays (e.g. Field, Jones and Thomlinson, 1967; Barendsen and Broerse, 1969; Fowler et al., 1972) . However, a natural process of reoxygenation of these hypoxic cells may occur in the intervals between doses if a fractionated course of irradiation is given . In such circumstances neutrons would be expected to lose some, or even all, of their advantage over x-ray treatment. It has been postulated on the basis of the proliferation kinetics and the initial response to irradiation (Denekamp, 1968 (Denekamp, , 1972 ) that animal sarcomata which do not shrink rapidly after large doses of radiation will not reoxygenate extensively and therefore will benefit from a treatment such as neutron therapy, whereas rapidly shrinking experimental carcinomata may overcome their hypoxic cell problem by an efficient natural process of reoxygenation. A loss of therapeutic gain with neutrons has been observed in fractionated experiments on a mouse mammary carcinoma (Fowler et al., 1972) which was known to reoxygenate extensively (Howes, 1969) ; however, in a rat fibrosarcoma with less reoxygenation neutrons were found to be more effective than x-rays even if a fractionated regimen was used (Field, Jones and Thomlinson, 1968) . The effect of single doses and two fractions of x-rays and neutrons was therefore tested on another rapidly growing fibrosarcoma.
MATERIALS AND METHODS
The CBA sarcoma used in the present experiments (Sarcoma F) was obtained from Hewitt, who has previously described its origin and its use in various radiobiological studies involving measurements of cell survival (Hewitt and Wilson, 1961; Hewitt, 1966) . The tumour was transplanted subcutaneously on the ventral wall of the thorax of 3-month old male mice. The growth of the tumours was recorded by measuring 3 perpendicular diameters. Tumours were selected for irradiation when they reached a mean diameter of between 7-5 and 10 mm, at which size they had a volume doubling time of one day and virtually no cell loss (Begg, personal communication Figure 3 shows the dose response curves obtained by the new method of integrating the area over each growth curve, i.e. by subtracting the mean diameter for each day from an arbitrary size of 12 mm mean diameter, and correcting for the rather small differences in mean size at the day of irradiation. In this way all the growth measurements are used, rather than the few that define the time to cross a given arbitrary size limit, or the size similarity in the two figures is probably because this sarcoma, like many others, does not shrink below 4-6 mm even after high doses. In carcinomata the smallest volume achieved before regrowth is more dose dependent.
The RBE values for fast neutrons and the (D2-D1)48 h values for x-rays and neutrons were measured from the doses to achieve the same effect in Fig. 2 and 3 . The RBE is the ratio of x-ray and neutron doses to produce the same effect.
(D2-D1)48 h is the dose increment needed to produce the same level of damage when the dose is given in two fractions D2 or in a single dose D1. The RBE was found to vary with the degree of damage, as has been observed previously (Field and Hornsey, 1971) . RBE values at various dose levels are shown in Table I ; values of 2-4-3-3 were found for single doses of neutrons, being lowest at 1000 rad of neutrons. Similar or slightly higher RBE values of between 2-6 and 3-9 were found for 2 fractions/48 h, again being lowest for low doses. The (D2-D1)48 h for x-rays is positive for the low doses and is negative at higher doses (Table II) in vivo (Hewitt and Wilson, 1961; Hewitt, 1966) .
In the present experiment most of the irradiations were performed on animals breathing warm oxygen in order to compare with other results (Hawkes et al. 1968; Fowler et al., 1972) . A comparison of the animals which received single doses of x-rays breathing either oxygen or air shows that the dose administered to oxygen breathing animals was more effective than that given in air (Fig. 2, 3 ). This is interpreted as due to improved oxygenation of some of the hypoxic cells in this tumour when the animals breathe oxygen, but raises the question of why virtually no increase in sensitivity was observed by Hewitt (1966) by the transplantation assay technique, but will die if left in situ. It is possible that in unanaesthetized mice (in Hewitt's experiments) there is a physiological response to hyperbaric oxygen which results in vascular constriction and counteracts the beneficial effects of additional 02 availability in the blood (Johnson, 1971; Milne, Hill and Bush, 1973) . This could be absent from the present experiments because the mice were anaesthetized with Nembutal. In the present experiments there was a sparing effect of dose fractionation for x-ray doses per fraction up to 1500 rad, and for neutron doses per fraction up to 500 rad (Table II) . At higher doses, however, the curves in Fig. 2 and 3 cross over, i.e. two doses are more effective than a single dose. A similar phenomenon after x-irradiation was also observed with spontaneous and transplanted mammary carcinomata (Hawkes et al., 1968) and with the rat fibrosarcoma RIB 5 (Field et al., 1968) . The explanation given was that reoxygenation was more than counteracting the effect of recovery from sublethal injury in the air breathing animals, but only at high doses. The same explanation is suggested for the present tumour.
In spite of the probability of some reoxygenation occurring between the fractions in the present sarcoma F, the RBE for neutrons stays high whether the dose is administrered as one or two fractions.
For single doses the RBE is high at low doses where differences in the accumulation of sublethal injury predominate, falls at intermediate dose levels (i.e. 1000 rad) and rises again at high doses where the hypoxic cell response plays a large part in the response of the tumour. For two fractions the RBE also rises at the hioher doses, suggesting that hypoxic cells are still important, i.e. reoxygenation, if it occurs, is inadequate. Table III summarizes the RBE data for fractionated neutron irradiation of animal tumours on the Hammersmith cyclotron (Field et al., 1968; Fowler et al., 1972; Fowler, Denekamp and Field, 1974) . Since different endpoints have been used in the three experiments, high levels of delay in regrowth of the sarcomata have been used for comparison with the local control experiments on the C3H mammary carcinoma. However, similar RBEs have been obtained for local control and for regrowth (Fowler et al., 1972; Field et al., 1968) . The RBE is high for single doses to all three tumours (3.1 for sarcoma F, 3-6 for RIB5 and 3-3 for the mammary carcinoma), confirming the presence of hypoxic cells which are resistant to x-irradiation. With fractionation, the RBE will fall if extensive reoxygenation occurs, but will remain high if hypoxic cells are still a major problem. However, at low doses the RBE will rise again because of a (Field, Jones and Thomlinson, 1968) . (c) Local control at 150 days (Fowler et (li., 1972 and Field, 1974 reduced ability to accumulate sublethal injury after neutron compared with xirradiation. In order to assess the relative usefulness, a therapeutic gain factor TGF can be calculated from the ratio of RBE tumour to RBE normal tissue at the same level of dose. This is also shown in Table  III ; RBE values for skin have been obtained from the curve for RBE as a function of dose per fraction (Field and Hornsey, 1971) . The TGF values are 1 8-2 1 for single doses to these three tumours; with fractionation the values range from 14 to 2-2 in the sarcomata, but fall to l 1-0 9 in the mammary carcinoma. TGF values of unity show that no advantage will be gained using neutrons relative to x-rays for that type of tumour. Although reoxygenation differences could account for the difference in TGF for fractionated irradiation of carcinomata and sarcomata, differences in inherent cell radiosensitivity cannot be excluded. The existing experimental data support the view that slowly shrinking experimental sarcomata may have inadequate reoxygenation processes and should therefore benefit from neutron therapy during fractionated irradiation. In rapidly shrinking experimental carcinomata on the other hand, although they may show the same great advantage of neutrons when tested with single dose experiments, the advantage will be lost if shrinkage occurs during the multifraction irradiation and is accompanied by extensive reoxygenation, so that hypoxic cells are not a real problem, as in the tumour described by Fowler et al. (1972 
